A spokesperson from Barclays Plc confirmed to Reuters that the British bank had hired Jim Birchenough from Wells Fargo & Co as its new chairman of global healthcare investment banking.
Before taking the position at Barclays, Birchenough last acted as the vice chairman of biopharma investment banking at Wells Fargo. This is not his first tenure with Barclays, however, having previously worked at the British investment bank as a research analyst with a focus on biotech companies.
During his earlier career, Birchenough also worked in similar roles in the biotech space at BMO Capital Markets and Lehman Brothers.
His new list of responsibilities at Barclays includes leading the bank’s global biopharma investment banking unit alongside Alexis de Rosnay, who joined Barclays last year.
“Jim has a real track record and it’s well known within the industry, both from his tenure as a banker and his tenure as a research analyst,” Richard Landgarten, global head of healthcare and real estate investment banking at Barclays said of Birchenough.